According to Werewolf Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 14.3592. At the end of 2023 the company had a P/S ratio of 7.01.
Year | P/S ratio | Change |
---|---|---|
2023 | 7.01 | 82.29% |
2022 | 3.84 | |
2021 | N/A |